Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 1/20 | 0.68 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.68 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.68 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.57 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.56 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.56 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.56 |
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
| ▸ | SOS1 | Q07889 | 1/20 | 0.48 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.48 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.47 |
| ▸ | ESR1 | P03372 | 1/20 | 0.47 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.46 |
| ▸ | CA12 | O43570 | 1/20 | 0.45 |
| ▸ | MAOB | P27338 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL84188 | 0.87 | SLC6A2 (0.66) | SLC6A2SLC6A4SLC6A3GSTP1HDAC4 | |
| SCHEMBL29618929 | 0.87 | SLC6A2 (0.66) | SLC6A2SLC6A4SLC6A3GSTP1HDAC4 | |
| SCHEMBL30610922 | 0.87 | SLC6A2 (0.66) | SLC6A2SLC6A4SLC6A3GSTP1HDAC4 | |
| SCHEMBL31621279 | 0.85 | SLC6A2 (0.64) | SLC6A2SLC6A4SLC6A3GSTP1HDAC4 | |
| SCHEMBL31621280 | 0.85 | SLC6A2 (0.64) | SLC6A2SLC6A4SLC6A3GSTP1HDAC4 | |
| SCHEMBL7787046 | 0.85 | SLC6A2 (0.64) | SLC6A2SLC6A4SLC6A3GSTP1HDAC4 | |
| Bromide SCHEMBL7032662 | 0.85 | SLC6A2 (0.64) | SLC6A2SLC6A4SLC6A3GSTP1HDAC4 | |
| SCHEMBL16683936 | 0.81 | SLC6A3 (1.00) | SLC6A2SLC6A4SLC6A3GSTP1HDAC4 | |
| SCHEMBL9189732 | 0.81 | MEN1 (0.65) | SLC6A2SLC6A4SLC6A3GSTP1HDAC4 | |
| SCHEMBL28361773 | 0.81 | SLC6A2 (0.59) | SLC6A2SLC6A4SLC6A3GSTP1HDAC4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130315834-A1 | NANOPROBE COMPRISING GOLD COLLOID NANOPARTICLES FOR MULTIMODALITY OPTICAL IMAGING OF CANCER AND TARGETED DRUG DELIVERY FOR CANCER | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2013-11-28 | — | — | US | claimed |
| WO-2012039685-A1 | A NANOPROBE COMPRISING GOLD COLLOID NANOPARTICLES FOR MULTIMODALITY OPTICAL IMAGING OF CANCER AND TARGETED DRUG DELIVERY FOR CANCER | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2012-03-29 | — | — | WO | claimed |
| WO-1992011295-A1 | UV/EB CURABLE BUTYL COPOLYMERS FOR COATING APPLICATIONS | EXXON CHEMICAL PATENTS INC. (US) | 1992-07-09 | — | — | WO | claimed |
| WO-1992011322-A2 | UV/EB CURABLE BUTYL COPOLYMERS FOR LITHOGRAPHIC AND CORROSION-RESISTANT COATING APPLICATIONS | EXXON CHEMICAL PATENTS INC. (US) | 1992-07-09 | — | — | WO | claimed |
| CN-119948083-A | Curable composition | 株式会社大赛璐 | 2025-05-06 | — | — | CN | disclosed |
| CN-118076767-A | Method and formulation for producing an optical metal oxide layer | 默克专利有限公司 | 2024-05-24 | — | — | CN | disclosed |
| CN-117561581-A | Insulated wire, coil including insulated wire, and cable | 株式会社大赛璐 | 2024-02-13 | — | — | CN | disclosed |
| CN-112313284-B | Curable composition | 株式会社大赛璐 | 2023-11-03 | — | — | CN | disclosed |
| CN-114829416-B | Curable composition | 株式会社大赛璐 | 2023-10-20 | — | — | CN | disclosed |
| CN-116323700-A | Curable compound product | 株式会社大赛璐 | 2023-06-23 | — | — | CN | disclosed |
| CN-114829416-A | Curable composition | 株式会社大赛璐 | 2022-07-29 | — | — | CN | disclosed |
| WO-2022075325-A1 | CURABLE COMPOUND PRODUCT | 株式会社ダイセル | 2022-04-14 | — | — | WO | disclosed |
| EP-0195846-A2 | Photo-curable epoxy resin type composition and curing process | KABUSHIKI KAISHA TOSHIBA (JP) | 1986-10-01 | — | — | EP | disclosed |
| US-4599155-A | POLYORTHOESTERS;SHRINKAGE INHIBITION;NONCRACKING;COATINGS | KABUSHIKI KAISHA TOSHIBA (JP) | 1986-07-08 | — | — | US | disclosed |
| EP-0172330-A1 | Photocurable composition | KABUSHIKI KAISHA TOSHIBA (JP) | 1986-02-26 | — | — | EP | disclosed |
| EP-0139234-A2 | Resin composition | KABUSHIKI KAISHA TOSHIBA (JP) | 1985-05-02 | — | — | EP | disclosed |
| EP-0135887-A2 | Photocurable composition | KABUSHIKI KAISHA TOSHIBA (JP) | 1985-04-03 | — | — | EP | disclosed |
| EP-0123842-A1 | Photo-curable epoxy resin type composition | KABUSHIKI KAISHA TOSHIBA (JP) | 1984-11-07 | — | — | EP | disclosed |
| EP-0114258-A1 | Resin encapsulation type photo-semiconductor devices | KABUSHIKI KAISHA TOSHIBA (JP) | 1984-08-01 | — | — | EP | disclosed |
| EP-0005380-B1 | PHOTOTROPIC PHOTOSENSITIVE COMPOSITIONS CONTAINING A FLUORAN COLORFORMER | Dynachem Corporation (US) | 1982-01-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130315834-A1 | NANOPROBE COMPRISING GOLD COLLOID NANOPARTICLES FOR MULTIMODALITY OPTICAL IMAGING OF CANCER AND TARGETED DRUG DELIVERY FOR CANCER | CD47, ALB, HCCS | SLC6A2 1390/4885SLC6A4 2731/4885SLC6A3 761/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.